Business Today: Latest Business News, India economy News, Stock Markets, Sensex, Mutual Funds and Indian Tax
Loading...
Search

Total 318 results found. Search for [ PB-Jayakumar ]

Results 1 to 21 of 318
PB Jayakumar
January 17, 2020
Piramal says his flagship Piramal Enterprises will utilise that money for further business expansion


PB Jayakumar
January 17, 2020
The deal will give Piramal $900 million on closing and $50 million to be received at the end of 12 months from the date of closing


PB Jayakumar
January 16, 2020
Wockhardt latest medicines: Wockhardt announces two new drugs for skin infections, its shares rise by 14 per cent intraday. Here's what this means


PB Jayakumar
January 15, 2020
It is estimated that so far only less than 30,000 jewellers have registered with the Bureau of Indian Standards (BIS) and a majority of the units in the unorganised sector are yet to register with the quality control organisation


PB Jayakumar
New Delhi, January 15, 2020
Budget 2020: According to a recent research report from analyst firm ICRA, gold jewellery demand may remain subdued in FY20 with growth in the range of 6-8 per cent due to elevated gold prices


PB Jayakumar
January 14, 2020
A couple of days ago, Lupin said that it had received two observations from the US health regulator following the inspection at its Nagpur manufacturing facility, one of its most modern plants


PB Jayakumar
January 10, 2020
If 2017-18 saw private sector players adding 2,280 MW out of a target of 2940 MW, only 972 MW of private capacity was added in 2018-19


PB Jayakumar
January 10, 2020
According to data from the World Gold Council (WGC), India has the 10th largest gold reserves. Here's what this means for you


PB Jayakumar
January 8, 2020
India may not face crude oil shortage if the tensions in the middle east escalate even to a war, as many countries such as Saudi Arabia, Venezuela or other Mediterranean and Middle East countries can assure supplies to the country


PB Jayakumar
New Delhi, January 7, 2020
How the merger of MNC giants Bayer and Monsanto is likely to pan out in India


PB Jayakumar
January 6, 2020
Indian corporates have been increasingly procuring renewable power through the open access route, mainly to meet decarbonisation targets and cost savings because of lower cost of renewable power vis-a-vis other sources


PB Jayakumar
December 31, 2019
Ratings agency Icra revised its outlook for India's renewable energy sector this week from stable to negative. Icra expects no growth in capacity addition in FY20


PB Jayakumar
December 30, 2019
The USFDA's Office of Manufacturing Quality (OMQ) at the Centre for Drug Evaluation Research (CDER) evaluates compliance with cGMP for drugs based on inspection reports and evidence gathered by USFDA investigators


PB Jayakumar
December 28, 2019
Nutraceuticals, which consist of vitamins and minerals, protein supplements, energy drinks and growth supplements, have clocked higher growth than prescription drugs


PB Jayakumar
New Delhi, December 26, 2019
Sun Pharma's issues with Halol was started in 2015, as the FDA issued a 'warning letter' subsequent to an inspection in September 2014


PB Jayakumar
December 25, 2019
ICRA which studied the revenues of top six listed hospitals for the second quarter of FY20, said the aggregate revenues of these companies grew 14 per cent year-on-year to Rs 4,807 crore


PB Jayakumar
December 21, 2019
The company said its wholly-owned subsidiary Valley Holdings has acquired the remaining 25 per cent partnership interest in Tata Chemicals (Soda Ash) Partners Holdings (which owns TCNA) from the Andover Group, a subsidiary of Owens-Illinois, for $195 million (nearly Rs 1,386.7 crore)


PB Jayakumar
December 19, 2019
Arjun Deshpande's unique pharmacy chain Generic Aadhar sells generic medicines to the masses at much cheaper rates than the market price


PB Jayakumar
December 17, 2019
According to the report 'India: the emerging hub for biologics and biosimilars', the Indian pharmaceutical companies have launched 123 biosimilars and currently have 201 active biosimilars covering multiple indications in the development pipeline


PB Jayakumar
Mumbai, December 13, 2019
The Indian industry is going through disruptions but that does not mean that you will die if you don't disrupt, said Pradhan, noting that data is the new oil and the government is formulating a new data policy


PAGES 1 OF 16  12345